LYTLE PAUL J 4
4 · PEREGRINE PHARMACEUTICALS INC · Filed May 8, 2012
Insider Transaction Report
Form 4
LYTLE PAUL J
Chief Financial Officer
Transactions
- Award
Non-Qualified Stock Options (right to buy)
2012-05-04+200,000→ 607,500 totalExercise: $0.46From: 2012-08-04Exp: 2022-05-04→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]This option vests quarterly over a two year period.